Evidence map›Paper›PMID 28371323›Full record

ArticleCNS neuroscience & therapeutics2017

Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®).

Alejandro Romero, Esther Parada, Laura González-Lafuente, Victor Farré-Alins, Eva Ramos, Ramón Cacabelos, Javier Egea

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS neuroscience & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alejandro RomeroDepartamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
Esther ParadaMolecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.
Laura González-LafuenteMolecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.
Victor Farré-AlinsMolecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.
Eva RamosDepartamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
Ramón CacabelosEuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain.
Javier EgeaMolecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.ORCID 0000-0003-4704-3019

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalBrain IschemiaCell Line, TumorCell SurvivalDose-Response Relationship, DrugDrug Evaluation, PreclinicalHippocampusHumansInflammationLipopolysaccharidesMiceMicrogliaNeuroprotective AgentsOligomycinsOxidative StressAnti-Inflammatory Agents, Non-SteroidalLipopolysaccharidesNeuroprotective Agentsoligomycin AOligomycinsOxidopaminePlant PreparationsRotenone

Identifiers

PMID28371323
PMCPMC6492656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.